Primary graft dysfunction in donor after brain death vs normothermic regional perfusion heart transplants

Melissa Vu Maffei1, Jade M Kozuch1, Mark Mariski1

  • 1University of California San Diego Health, La Jolla, CA.

JHLT Open
|January 5, 2026
PubMed

Insights

Normothermic regional perfusion (NRP) for donors after circulatory death (DCD) heart transplants, while increasing organ utilization, is associated with a higher risk of primary graft dysfunction (PGD). Further research is needed to understand and mitigate this risk.

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Medicine
  • Organ Procurement

Background:

  • Primary graft dysfunction (PGD) is a major cause of early mortality after heart transplantation (HT).
  • Donors after circulatory death (DCD) are increasingly used for HT, with normothermic regional perfusion (NRP) as a key procurement technique.
  • This study compares PGD incidence and risk factors between donors after brain death (DBD) and DCD/NRP heart allografts.

Purpose of the Study:

  • To assess the incidence of PGD in heart transplants using DBD versus DCD allografts procured with NRP.
  • To identify risk factors associated with PGD in these distinct donor types.

Main Methods:

  • Retrospective cohort analysis of adult heart-only transplants (1/1/21–6/30/23).
  • Utilized modified ISHLT 2014 Consensus Criteria for PGD diagnosis.
  • Risk factors analyzed using univariable and multivariable logistic regression.

Main Results:

  • The DCD/NRP group showed a non-significantly higher PGD incidence (22% vs. 13%, p=0.11).
  • Multivariable analysis revealed NRP was significantly associated with increased PGD risk (OR 2.88, p=0.02).
  • PGD patients experienced longer ICU stays and higher rates of renal replacement therapy, but midterm mortality and cardiac function were similar.

Conclusions:

  • After adjusting for confounders, NRP procurement is linked to a higher risk of PGD compared to DBD.
  • While PGD increases short-term resource utilization, midterm outcomes do not significantly differ.
  • Further investigation is required to elucidate NRP-specific characteristics contributing to PGD risk.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849